264 related articles for article (PubMed ID: 11452160)
1. WBC-reduced platelet concentrates from pooled buffy coats in additive solution: an evaluation of in vitro and in vivo measures.
van der Meer PF; Pietersz RN; Tiekstra MJ; Huijgens PC; Dekker WJ; Reesink HW
Transfusion; 2001 Jul; 41(7):917-22. PubMed ID: 11452160
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
[TBL] [Abstract][Full Text] [Related]
3. Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study.
de Wildt-Eggen J; Nauta S; Schrijver JG; van Marwijk Kooy M; Bins M; van Prooijen HC
Transfusion; 2000 Apr; 40(4):398-403. PubMed ID: 10773049
[TBL] [Abstract][Full Text] [Related]
4. WBC content of platelet concentrates prepared by the buffy coat method using different processing procedures and storage solutions.
de Wildt-Eggen J; Schrijver JG; Bins M
Transfusion; 2001 Nov; 41(11):1378-83. PubMed ID: 11724981
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a whole-blood WBC-reduction filter that saves platelets: in vitro studies.
Larsson S; Gulliksson H; Paunovic D
Transfusion; 2001 Apr; 41(4):534-9. PubMed ID: 11316906
[TBL] [Abstract][Full Text] [Related]
6. Storage of platelets in additive solution for up to 12 days with maintenance of good in-vitro quality.
van der Meer PF; Pietersz RN; Reesink HW
Transfusion; 2004 Aug; 44(8):1204-11. PubMed ID: 15265125
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new citrate-acetate-NaCl platelet additive solution for the storage of white cell-reduced platelet concentrates obtained from half-strength CPD pooled buffy coats.
van Rhenen DJ; Vermeij H; Kappers-Klunne M; Payrat JM
Transfusion; 1995 Jan; 35(1):50-3. PubMed ID: 7998070
[TBL] [Abstract][Full Text] [Related]
8. Platelets stored in a new-generation container differences between plasma and platelet additive solution II.
de Wildt-Eggen J; Schrijver JG; Smid WM; Joie M; Bollinne V; Bins M
Vox Sang; 1998; 75(3):218-23. PubMed ID: 9852410
[TBL] [Abstract][Full Text] [Related]
9. Determination
Thuku NW; Shikuku K; Mbugua A
Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
Bertolini F; Rebulla P; Riccardi D; Cortellaro M; Ranzi ML; Sirchia G
Transfusion; 1989 Sep; 29(7):605-9. PubMed ID: 2773027
[TBL] [Abstract][Full Text] [Related]
11. In-vivo evaluation of random donor platelet concentrates from pooled buffy coats.
Klüter H; Dörges L; Maass E; Wagner T; Bartels H; Kirchner H
Ann Hematol; 1996 Aug; 73(2):85-9. PubMed ID: 8774617
[TBL] [Abstract][Full Text] [Related]
12. Storage of platelets in additive solutions: effects of phosphate.
Gulliksson H; Larsson S; Kumlien G; Shanwell A
Vox Sang; 2000; 78(3):176-84. PubMed ID: 10838519
[TBL] [Abstract][Full Text] [Related]
13. Influence of a 12-hour, 22 degrees C holding period for buffy coats on the preparation of platelet concentrates stored in plasma.
Boeri N; Saleun S; Pelissier E; Saleun JP; Aiach M; Rendu F
Transfusion; 1994 Oct; 34(10):881-6. PubMed ID: 7940660
[TBL] [Abstract][Full Text] [Related]
14. Clinical and laboratory experience with erythrocyte and platelet preparations from a 0.5CPD Erythro-Sol opti system.
Högman CF; Eriksson L; Wallvik J; Payrat JM
Vox Sang; 1997; 73(4):212-9. PubMed ID: 9407638
[TBL] [Abstract][Full Text] [Related]
15. Cytokine levels as performance indicators for white blood cell reduction of platelet concentrates.
Wadhwa M; Krailadsiri P; Dilger P; Gaines Das R; Seghatchian MJ; Thorpe R
Vox Sang; 2002 Aug; 83(2):125-36. PubMed ID: 12201842
[TBL] [Abstract][Full Text] [Related]
16. In vivo PLT increments after transfusions of WBC-reduced PLT concentrates stored for up to 7 days.
Dijkstra-Tiekstra MJ; Pietersz RN; Hendriks EC; Reesink HW; Huijgens PC
Transfusion; 2004 Mar; 44(3):330-6. PubMed ID: 14996188
[TBL] [Abstract][Full Text] [Related]
17. Leucoreduced platelet concentrates in additive solution: an evaluation of filters and storage containers.
van der Meer P; Pietersz R; Reesink H
Vox Sang; 2001; 81(2):102-7. PubMed ID: 11555469
[TBL] [Abstract][Full Text] [Related]
18. Storage of platelets in additive solutions: a new method for storage using sodium chloride solution.
Gulliksson H; Sallander S; Pedajas I; Christenson M; Wiechel B
Transfusion; 1992 Jun; 32(5):435-40. PubMed ID: 1626346
[TBL] [Abstract][Full Text] [Related]
19. Preparation of leukodepleted platelet concentrates from pooled buffy coats: prestorage filtration with Autostop BC.
Pietersz RN; van der Meer PF; Steneker I; Hinloopen B; Dekker WJ; van Zanten AP; Reesink HW
Vox Sang; 1999; 76(4):231-6. PubMed ID: 10394143
[TBL] [Abstract][Full Text] [Related]
20. Platelet storage lesion of WBC-reduced, pooled, buffy coat-derived platelet concentrates prepared in three in-process filter/storage bag combinations.
Krailadsiri P; Seghatchian J; Williamson LM
Transfusion; 2001 Feb; 41(2):243-50. PubMed ID: 11239230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
